SEC Form 4 · accession 0001574774-18-000052

BIOTELEMETRY, INC. · BEAT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President & CEO · Director

Period of report

Jul 26, 2018

Accepted (ET)

Jul 30, 2018 · 5:26 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001574774

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jul 26, 2018	M	209,154	$6.56	A	387,509	D
Common Stock^F2	Jul 26, 2018	S	209,154	$54.26	D	178,355	D
Common Stock	Jul 27, 2018	M	90,846	$6.56	A	269,201	D
Common Stock^F3	Jul 27, 2018	S	90,846	$53.14	D	178,355	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)^F4	$6.56	Jul 26, 2018	M	209,154	D	—	Jun 15, 2020	Common Stock	209,154	90,846	D
Stock Options (Right to Buy)^F4	$6.56	Jul 27, 2018	M	90,846	D	—	Jun 15, 2020	Common Stock	90,846	0	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2018.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $51.70 to $57.30, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $52.55 to $55.30, inclusive.
F4The stock options vested in four equal annual installments, which began on June 15, 2011. The options were fully exercisable as of June 15, 2014.